(Hypertension. 2002;39:251.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Cardiovascular Disease Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University (R.D.B., Y.W.), Durham; National Institute on Alcohol Abuse & Alcoholism, National Institutes of Health (S.B., Z.J., L.O., G.K.), Bethesda, Md; and Department of Biological Sciences, Western Michigan University (W.F.J.), Kalamazoo.
Correspondence to Richard Bukoski, PhD, Director, Cardiovascular Disease Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, 700 George St, Durham, NC 27707. E-mail rbukoski{at}wpo.nccu.edu
Mesenteric branch arteries isolated from cannabinoid type 1 receptor knockout (CB1-/-) mice, their wild-type littermates (CB1+/+ mice), and C57BL/J wild-type mice were studied to test the hypothesis that murine arteries undergo high sensitivity Ca2+-induced relaxation that is CB1 receptor dependent. Confocal microscope analysis of mesenteric branch arteries from wild-type mice showed the presence of Ca2+ receptor-positive periadventitial nerves. Arterial segments of C57 control mice mounted on wire myographs contracted in response to 5 µmol/L norepinephrine and responded to the cumulative addition of extracellular Ca2+ with a concentration-dependent relaxation that reached a maximum of 72.0±6.3% of the prerelaxation tone and had an EC50 for Ca2+ of 2.90±0.54 mmol/L. The relaxation was antagonized by precontraction in buffer containing 100 mmol/L K+ and by pretreatment with 10 mmol/L tetraethylammonium. Arteries from CB1-/- and CB1+/+ mice also relaxed in response to extracellular Ca2+ with no differences being detected between the knockout and their littermate controls. SR141716A, a selective CB1 antagonist, caused concentration-dependent inhibition of Ca2+-induced relaxation in both the knockout and wild-type strains (60% inhibition at 1 µmol/L). O-1918, a cannabidiol analog, had a similar blocking effect in arteries of both wild-type and CB1-/- mice at 10 µmol/L. In contrast, 1 µmol/L SR144538, a cannabinoid type 2 receptor antagonist, or 50 µmol/L 18
-glycyrrhetinic acid, a gap junction blocker, were without effect. SR141716A (1 to 30 µmol/L) was also assessed for nonspecific actions on whole-cell K+ currents in isolated vascular smooth muscle cells. SR141716A inhibited macroscopic K+ currents at concentrations higher than those required to inhibit Ca2+-induced relaxation, and appeared to have little effect on currents through large conductance Ca2+-activated K+ channels. These data indicate that arteries of the mouse relax in response to cumulative addition of extracellular Ca2+ in a hyperpolarization-dependent manner and rule out a role for CB1 or CB2 receptors in this effect. The possible role of a nonclassical cannabinoid receptor is discussed.
Key Words: mesenteric arteries calcium relaxation potassium channels
This article has been cited by other articles:
![]() |
M. Waldeck-Weiermair, C. Zoratti, K. Osibow, N. Balenga, E. Goessnitzer, M. Waldhoer, R. Malli, and W. F. Graier Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression J. Cell Sci., May 15, 2008; 121(10): 1704 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Awumey, S. K. Hill, D. I. Diz, and R. D. Bukoski Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2363 - H2370. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Awumey, A. C. Howlett, J. W. Putney Jr., D. I. Diz, and R. D. Bukoski Ca2+ mobilization through dorsal root ganglion Ca2+-sensing receptor stably expressed in HEK293 cells Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1895 - C1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Awumey, A. C. Howlett, and D. I. Diz Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H520 - H521. [Full Text] [PDF] |
||||
![]() |
A. Kofalvi, R. J. Rodrigues, C. Ledent, K. Mackie, E. S. Vizi, R. A. Cunha, and B. Sperlagh Involvement of Cannabinoid Receptors in the Regulation of Neurotransmitter Release in the Rodent Striatum: A Combined Immunochemical and Pharmacological Analysis J. Neurosci., March 16, 2005; 25(11): 2874 - 2884. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Batkai, P. Pacher, D. Osei-Hyiaman, S. Radaeva, J. Liu, J. Harvey-White, L. Offertaler, K. Mackie, M. A. Rudd, R. D. Bukoski, et al. Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension Circulation, October 5, 2004; 110(14): 1996 - 2002. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Koura, A. Ichihara, Y. Tada, Y. Kaneshiro, H. Okada, C. J. Temm, M. Hayashi, and T. Saruta Anandamide Decreases Glomerular Filtration Rate through Predominant Vasodilation of Efferent Arterioles in Rat Kidneys J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1488 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Begg, F.-M. Mo, L. Offertaler, S. Batkai, P. Pacher, R. K. Razdan, D. M. Lovinger, and G. Kunos G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current J. Biol. Chem., November 14, 2003; 278(46): 46188 - 46194. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, E. K. Awumey, P. K. Chatterjee, C. Somasundaram, K. Bian, K. V. Rogers, C. Dunn, and R. D. Bukoski Molecular cloning and characterization of a rat sensory nerve Ca2+-sensing receptor Am J Physiol Cell Physiol, July 1, 2003; 285(1): C64 - C75. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Clement, E. G. Hawkins, A. H. Lichtman, and B. F. Cravatt Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase J. Neurosci., May 1, 2003; 23(9): 3916 - 3923. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Offertaler, F.-M. Mo, S. Batkai, J. Liu, M. Begg, R. K. Razdan, B. R. Martin, R. D. Bukoski, and G. Kunos Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor Mol. Pharmacol., March 1, 2003; 63(3): 699 - 705. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |